Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosides
- 1 June 1983
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 23 (6), 799-802
- https://doi.org/10.1128/aac.23.6.799
Abstract
Enterococcal endocarditis is usually treated with a combination of a penicillin and an aminoglycoside. Recent reports have documented the emergence of enterococci in France with high-level resistance to gentamicin, tobramycin, and kanamycin and the emergence of strains in Houston, Tex. with high-level resistance to all of these drugs and streptomycin. In this study, we examined strains from a geographic area where newer aminoglycosides have been less commonly used. Of 125 distinct patient isolates, 18 (14%) were resistant to greater than 2,000 micrograms of gentamicin and most other aminoglycosides per ml. Four of these strains transferred gentamicin resistance to a laboratory recipient. One strain, chosen for further study, was resistant to synergism between penicillin and gentamicin, tobramycin, kanamycin, streptomycin, and amikacin and demonstrated the following enzymatic activities: 3'- and 2"-aminoglycoside phosphotransferases, 6'-aminoglycoside acetyltransferase, and adenylylation of streptomycin. Optimal therapy for endocarditis caused by such highly resistant strains is currently unknown.This publication has 17 references indexed in Scilit:
- Aminoglycoside-modifying enzyme content of a multiply resistant strain of Streptococcus faecalisJournal of Antimicrobial Chemotherapy, 1983
- Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wallAntimicrobial Agents and Chemotherapy, 1980
- Evidence of plasmid-mediated production of aminoglycoside-modifying enzymes not previously described in AcinetobacterAntimicrobial Agents and Chemotherapy, 1980
- High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenesAntimicrobial Agents and Chemotherapy, 1979
- Plasmid-Determined Resistance to Antimicrobial AgentsAnnual Review of Microbiology, 1978
- Aminoglycoside-Inactivating Enzymes in Clinical Isolates of Streptococcus FaecalisJCI Insight, 1978
- Resistance to Six Aminoglycosidic Aminocyclitol Antibiotics Among Enterococci: Prevalence, Evolution, and Relationship to Synergism with PenicillinAntimicrobial Agents and Chemotherapy, 1977
- Mechanisms of Antibiotic Resistance in BacteriaAnnual Review of Biochemistry, 1973
- Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical CenterArchives of Internal Medicine, 1970
- Susceptibility of Group D Streptococcus (Enterococcus) to 21 Antibiotics In Vitro, with Special Reference to Species DifferencesThe American Journal of the Medical Sciences, 1969